Canada’s biotechnology industry is entering a defining era of scientific innovation, global investment, and clinical excellence. The Leading 10 Canadian Biotech Companies of 2026 report highlights the organizations transforming healthcare through breakthroughs in neuroscience, oncology, autoimmune diseases, regenerative medicine, cardiovascular care, antibody engineering, and AI-enabled drug discovery. Together, these companies have invested more than US$700...
Takeaways: The approval should help Kardium gain early adoption in Canada by offering a single-catheter solution that combines high-density mapping and PFA with strong PULSAR data (78% 12‑month freedom from atrial arrhythmia and 0% device-related primary safety events), which can be compelling versus legacy thermal ablation and emerging PFA competitors. Over time, this could support broader commercialization,...
